欢迎来到 CSNpharm! 产品仅用于科研!
首页 Compound Arrays 促销产品
400-920-2911 sales@csnpharm.cn    

Featured Products

Cat. No. Product Name CAS No. Information
CSN16614 Naringin  10236-47-2 Naringin is a flavanone glycoside, which exerts a variety of pharmacological effects such as antioxidant activity, blood lipid lowering, anticancer ac
CSN16708 Calcifediol  19356-17-3 Calcifediol is an active metabolite of vitamin D. It can inhibit the secretion of parathyroid hormone with 2 nM and commonly used as an indicator of b
CSN16776 Ketoconazole  65277-42-1 Ketoconazole is an imidazole anti-fungal agent which inhibits cyclosporine oxidase and testosterone 6 beta-hydroxylase with IC50 of 0.19 mM and 0.22 m
CSN16910 GSK1324726A  1300031-52-0 GSK1324726A is an inhibitor of BET proteins BRD2, BRD3, BRD4 with IC50 of 41 nM, 31 nM, and 22 nM respectively.
CSN17349 Cilengitide  188968-51-6 Cilengitide is a cyclic RGD pentapeptide antagonist of integrins αvβ3, αvβ5 and α5β1.
CSN17768 CPI-0610  1380087-89-7 CPI-0610 is an inhibitor of BET bromodomains BRD2, BRD3, BRD4, and BRDT via binding to the acetylated lysine recognition motifs.
CSN17894 UNC0642  1481677-78-4 UNC0642 is a selective inhibitor of G9a/GLP with IC50 of < 15 nM.
CSN17978 ETC-159  1638250-96-0 ETC-159 is a potent, orally available PORCN inhibitor. It inhibits β-catenin reporter activity with an IC50 of 2.9 nM.
CSN18277 Vipadenant  442908-10-3 Vipadenant is an adenosine antagonist with Ki of 1.3 nM and 68 nM for A2A and A1, respectively. Vipadenant is a selective A2A receptor antagonist wit
CSN18869 CFI-402257  1610759-22-2 CFI-402257 is a novel and selective Mps1 inhibitor with Ki value of 0.1 nM.
CSN19682 GSK2982772  1622848-92-3 GSK2982772 is an inhibitor of receptor interacting protein 1 (RIP1) with IC50 of 16 nM and it is used for the treatment of inflammatory diseases.
CSN20539 IVA-337  927961-18-0 IVA-337 is a agonist of peroxisome proliferator-activated receptors (PPAR) which is widely used in the study of lung fibrosis and pulmonary hypertensi
CSN21154 Lifitegrast  1025967-78-5 Lifitegrast is a novel small molecule integrin antagonist which can inhibit an integrin, lymphocyte function-associated antigen 1 (LFA-1), from bindin
CSN18830 Fevipiprant  872365-14-5 Fevipiprant is a selective, potent, reversible competitive CRTh2 antagonist with an in vitro dissociation constant KD value of 1.1nM at the CRTh2 rece
CSN19708 GSK2193874  1336960-13-4 GSK2193874 is a selective transient receptor potential vanilloid 4 (TRPV4) blocker with IC50 value of 0.04 μM.
CSN17916 GNE-9605  1536200-31-3 GNE-9605 is a selective and potent LRRK2 with IC50 value of 18.7 nM.
CSN17256 RBC8  361185-42-4 RBC8 is an inhibitor of GTPases RalA and RalB with IC50 of 3.5 μM in cell assay.
CSN17980 AZD9496  1639042-08-2 AZD9496 is a selective antagonist of estrogen receptor Erα (IC50 = 0.28 nM).
CSN19695 GLPG1690  1628260-79-6 GLPG1690, a first-in-class autotaxin (ATX) inhibitor with IC50 of 131 nM and Ki of 15 nMl, is able to cause a sustained reduction of LPA levels in pla
CSN21065 GLPG1837  1654725-02-6 GLPG-1837 is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator1, shows enhanced efficacy on CFTR mutants harboring Class III mu
CSN21094 AZD0364  2097416-76-5 AZD0364 is an ERK1 and​/or ERK2 kinase for the treatment of cancer.
CSN21071 AMG-3969  1361224-53-4 AMG-3969 is a glucokinase-GKRP disruptor with IC50 value of 343nM and potently reverses the inhibitory effect of GKRP on GK activity.
CSN20461 WT161  1206731-57-8 WT161 selectively inhibits HDAC6 that exhibits effective anti-tumor activities in multiple myeloma.
CSN17712 PF-4136309  1341224-83-6 PF-4136309 is a potent, Selective, and orally bioavailable CCR2 antagonist.
CSN18824 AZD0156  1821428-35-6 AZD0156 is a potent and selective inhibitors of ATM kinase, with potential chemo-/radio-sensitizing and antineoplastic activities.
CSN18633 UNBS5162  956590-23-1 UNBS5162 is a naphthalimide and a hydrolysis product of UNBS3157 that decreases CXCL chemokine expression in experimental prostate cancers and the mea
CSN19102 GNE-3511  1496581-76-0 GNE-3511 is a potent and selective zipper kinase (DLK, MAP3K12) inhibitors.
CSN19099 MGL-3196  920509-32-6 MGL-3196 is a selective thyroid hormone receptor β agonist with EC50s of 0.21 and 3.74 µM for TRβ and TRα respectively.
CSN17993 PT-2385  1672665-49-4 PT2385 is an inhibitor of hypoxia inducible factor (HIF)-2 alpha with antineoplastic effect.
CSN19143 PQR620  1927857-56-4 PRQ620 is a highly potent and selective mTORC1/2 inhibitor, shows anti-tumor effects in vitro and in vivo.
CSN20673 Leniolisib  1354690-24-6 Leniolisib is a potent and selective PI3Kδ inhibitor currently in used for the treatment of immunodeficiency disorders.
CSN17357 Velpatasvir  1377049-84-7 Velpatasvir is an inhibitor of hepatitis C virus nonstructural protein 5A (NS5A) (genotype 1 (GT1) to GT6 replicons).
CSN17164 PFI-1  1403764-72-6 PFI-1 is a highly selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 μM and for BRD2 with IC50 of 98 nM in a cell-fre
CSN22393 Elagolix Sodium  832720-36-2 Elagolix sodium is an antagonist of human GnRH receptor (GnRHR) with IC50 and Ki of 0.25 nM and 3.7 nM, respectively.
CSN16482 AZD1981  802904-66-1 AZD1981 is a potent and selective CRTh2 antagonist and displaces radio-labelled PGD2 from human recombinant DP2 with high potency (pIC50 = 8.4).
CSN22610 BMS-309403  300657-03-8 BMS-309403 is an inhibitor of fatty acid binding protein 4 (FABP4) with Ki of less than 2 nM that decreases fatty acid uptake in adipocytes in vitro.
CSN21376 AM-0902  1883711-97-4 Potent and selective TRPA1 antagonist (IC50 = 0.02 μM for human TRPA1). Exhibits no siginificant activity against human TRPV1 or TRPV4, and rat TRPV1,
CSN21371 LXH254  1800398-38-2 LXH254 is an ATP-competitive inhibitor of Raf with anti-proliferative activity. Phase I.
CSN21373 Risdiplam  1825352-65-5 Risdiplam is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN)
CSN23688 Tropifexor  1383816-29-2 Tropifexor is a potent agonist of FXR with EC50 of 0.26 nM.
CSN23775 VTX-27  1321924-70-2 VTX-27 is an inhibitor of protein kinase C θ (PKC θ) and PKC δ with Kis of 0.08 nM and 16 nM, respectively.
CSN23877 Acrizanib  1229453-99-9 Acrizanib is a selective VEGFR2 inhibitor with IC50 value of 17.4nM.
CSN23913 TUG-1375  2247372-59-2 TUG-1375 is a free fatty acid receptor 2 (FFA2/GPR43) inhibitor with pKi of 6.69.
CSN24076 JNJ-61432059  2035814-50-5 JNJ-61432059 is an oral active and selective negative modulator of AMPAR associated with trans-membrane AMPAR regulatory protein (TARP) γ-8, with a pI
CSN24192 GSK-2894631A  2101626-26-8 GSK-2894631A is a highly potent and selective HPGDS inhibitor with IC50 value of 9.9nM.
CSN24182 AMG 333  1416799-28-4 AMG 333 is a potent and selective TRPM8 antagonist with IC50 value of 13nM.
CSN24175 JAK/HDAC-IN-1  2284621-75-4 JAK/HDAC-IN-1 is a potent JAK2/HDAC dual inhibitor with improved antiproliferative and proapoptotic activities over SAHA and ruxolitinib in several he
CSN24193 A-420983  330789-03-2 A-420983 is a potent lck inhibitor, exhibiting oral efficacy in animal models of delayed-type hypersensitivity and organ transplant rejection.
CSN24178 DDD107498  1469439-69-7 DDD107498 is a multiple-stage antimalarial agent targeting on eEF2.
CSN24302 MK-7246  1218918-62-7 MK-7246 is a potent and selective CRTH2 antagonist with Ki value of 2.5nM.
<< PREV 1 NEXT >>